Healthcare Training Institute - Quality Education since 1979
CE for Psychologist, Social Worker, Counselor, & MFT!!

Section 23
Prevention of Substance Abuse: A Brief Overview

Question 23 | Test | Table of Contents

National Center for Biotechnology Information

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, click Ctrl + several times, then scroll.
Questions? Email: info@mentalhealthce.com

Medina-Mora, Maria Elena. Prevention of Substance Abuse: A Brief Overview. World Psychiatry, February 2005, p. 25-30.

Update
Exploring Arts-Based interventions
for Youth Substance Use Prevention:
A Scoping Review of Literature

Maina, G., Li, Y., Fang, Y., Amoyaw, J., Pandey, M., Herzog, T., Nkrumah, D., Sherstobitoff, J., & Mousavian, G. (2022). Exploring arts-based interventions for youth substance use prevention: a scoping review of literature. BMC public health, 22(1), 2281.

Peer-Reviewed Journal Article References:
Helle, A. C., Wycoff, A. M., Griffin, S. A., Fleming, M., Freeman, L. K., Vebares, T. J., Rodriguez, E. M., Zapata, M. F., & Trull, T. J. (2021). Co-use of medication and alcohol: The influence on subjective effects of intoxication and affect. Personality Disorders: Theory, Research, and Treatment.

Lindsey, A. C., Janich, N., Macchi, C. R., Cordes, C. C., Mendoza, N. S., Vazquez, E., & Heath-Martinez, C. (2021). Testing a Screening, Brief Intervention, and Referral to Treatment (SBIRT) interdisciplinary training program model for higher education systems. Families, Systems, & Health, 39(2), 212–223.

Roos, C. R., Bowen, S., & Witkiewitz, K. (2017). Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention. Journal of Consulting and Clinical Psychology, 85(11), 1041–1051. 

Stewart, S. H., Walitzer, K. S., Blanco, J., Swiatek, D., Paine Hughes, L., Quiñones-Lombraña, A., & Shyhalla, K. (2019). Medication-enhanced behavior therapy for alcohol use disorder: Naltrexone, Alcoholics Anonymous Facilitation, and OPRM1 genetic variation. Journal of Substance Abuse Treatment, 104, 7–14.

Tarter, R. E., Sambrano, S., & Dunn, M. G. (2002). Predictor variables by developmental stages: A Center for Substance Abuse Prevention multisite study. Psychology of Addictive Behaviors, 16(4, Suppl), S3–S10. 

Witkiewitz, K., & Bowen, S. (2010). Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. Journal of Consulting and Clinical Psychology, 78(3), 362–374.

QUESTION 23
What main categories of comorbidity can be identified, although for some patients it might not be clear which category they belong to? To select and enter your answer go to Test.